Multiple myeloma (MM) is a malignant disorder characterized by the clonal proliferation of plasma cells (PCs) in the bone marrow (BM). The genetic background and clinical course of the disease are lar
RNA expression profiling of control, single mutant (Ccnd1, MMSET or Ikk2ca) and double mutant (Ccnd1/Ikk2ca or MMSET/Ikk2ca) bone marrow plasma cells Overall design: Comparison of transcriptional prof
